The Humoral Immune Response to Monoclonal Antibody Therapy for Ovarian Cancer

1998 ◽  
Vol 95 (s39) ◽  
pp. 18P-19P
Author(s):  
S Nicholson ◽  
JL Gallop ◽  
H Band ◽  
J Taylor-Papadimitriou ◽  
AJT George ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Monoclonal Antibody ◽  
Immune Response ◽  
Humoral Immune Response ◽  
Antibody Therapy ◽  
Monoclonal Antibody Therapy ◽  
Humoral Immune

A Humanized Anti–4-1BB Monoclonal Antibody Suppresses Antigen-Induced Humoral Immune Response in Nonhuman Primates

2000 ◽  
Vol 23 (6) ◽  
pp. 613-621 ◽  
Author(s):  
Hyo J. Hong ◽  
Jae W. Lee ◽  
Sung Sup Park ◽  
Young Jun Kang ◽  
Sun Young Chang ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Immune Response ◽  
Humoral Immune Response ◽  
Nonhuman Primates ◽  
Humoral Immune

scholarly journals Impact of humoral immune response against p53 on clinical outcome of High-Grade Serous Ovarian Cancer (HGSOC) patients

2016 ◽  
Vol 27 ◽  
pp. viii8
Author(s):  
M. Garziera ◽  
E. Cecchin ◽  
M. Montico ◽  
R. Roncato ◽  
S. Gagno ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Immune Response ◽  
Clinical Outcome ◽  
Humoral Immune Response ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
Humoral Immune

Monoclonal antibody therapy of ovarian cancer

2005 ◽  
Vol 5 (1) ◽  
pp. 87-96 ◽  
Author(s):  
Christopher F Nicodemus ◽  
Jonathan S Berek
Keyword(s):  
Ovarian Cancer ◽  
Monoclonal Antibody ◽  
Antibody Therapy ◽  
Monoclonal Antibody Therapy

scholarly journals Vaccines and Immunotherapeutics for the Treatment of Malignant Disease

2010 ◽  
Vol 2010 ◽  
pp. 1-12 ◽  
Author(s):  
Joel F. Aldrich ◽  
Devin B. Lowe ◽  
Michael H. Shearer ◽  
Richard E. Winn ◽  
Cynthia A. Jumper ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Immune Response ◽  
Immune System ◽  
Malignant Disease ◽  
Cellular Therapy ◽  
Antibody Therapy ◽  
Cytokine Therapy ◽  
Monoclonal Antibody Therapy ◽  
Adoptive Cellular Therapy

The employment of the immune system to treat malignant disease represents an active area of biomedical research. The specificity of the immune response and potential for establishing long-term tumor immunity compels researchers to continue investigations into immunotherapeutic approaches for cancer. A number of immunotherapeutic strategies have arisen for the treatment of malignant disease, including various vaccination schemes, cytokine therapy, adoptive cellular therapy, and monoclonal antibody therapy. This paper describes each of these strategies and discusses some of the associated successes and limitations. Emphasis is placed on the integration of techniques to promote optimal scenarios for eliminating cancer.

Sign in / Sign up

Export Citation Format

Share Document